Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal
Tóm tắt
Current nutritional approaches to metabolic syndrome and type 2 diabetes generally rely on reductions in dietary fat. The success of such approaches has been limited and therapy more generally relies on pharmacology. The argument is made that a re-evaluation of the role of carbohydrate restriction, the historical and intuitive approach to the problem, may provide an alternative and possibly superior dietary strategy. The rationale is that carbohydrate restriction improves glycemic control and reduces insulin fluctuations which are primary targets. Experiments are summarized showing that carbohydrate-restricted diets are at least as effective for weight loss as low-fat diets and that substitution of fat for carbohydrate is generally beneficial for risk of cardiovascular disease. These beneficial effects of carbohydrate restriction do not require weight loss. Finally, the point is reiterated that carbohydrate restriction improves all of the features of metabolic syndrome.
Tài liệu tham khảo
American Diabetes Association: Nutrition Recommendations and Interventions for Diabetes-2007. Diabetes Care 2007,30(Suppl 1):S48-S65. 10.2337/dc07-S048
American Diabetes Association: Nutrition Recommendations and Interventions for Diabetes-2008. Diabetes Care 2008,31(Suppl 1):S61-S78. 10.2337/dc08-S061
Mann JI, De Leeuw I, Hermansen K, Karamanos B, Karlstrom B, Katsilambros N, Riccardi G, Rivellese AA, Rizkalla S, Slama G, et al.: Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 2004,14(6):373-394. 10.1016/S0939-4753(04)80028-0
Draznin B: Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes 2006,55(8):2392-2397. 10.2337/db06-0391
Reusch JE, Draznin BB: Atherosclerosis in diabetes and insulin resistance. Diabetes Obes Metab 2007,9(4):455-463. 10.1111/j.1463-1326.2006.00620.x
Bernstein R: Dr. Bernstein's Diabetes Solution: The Complete Guide to Achieving Normal Blood Sugars. Little, Brown and Company; 2007.
Nielsen JV, Jönsson E, Ivarsson A: A low carbohydrate diet in type 1 diabetes: clinical experience – a brief report. Ups J Med Sci 2005,110(3):267-273.
Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP: Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 2005,142(6):403-411.
Dashti HM, Mathew TC, Khadada M, Al-Mousawi M, Talib H, Asfar SK, Behbahani AI, Al-Zaid NS: Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem 2007.
Nielsen JV, Jönsson EA: Low-carbohydrate diet in type 2 diabetes. Stable improvement of bodyweight and glycaemic control during 22 months follow-up. Nutr Metab (Lond) 2006,3(1):22. 10.1186/1743-7075-3-22
Allick G, Bisschop PH, Ackermans MT, Endert E, Meijer AJ, Kuipers F, Sauerwein HP, Romijn JA: A low-carbohydrate/high-fat diet improves glucoregulation in type 2 diabetes mellitus by reducing postabsorptive glycogenolysis. J Clin Endocrinol Metab 2004,89(12):6193-6197. 10.1210/jc.2004-1041
Daly ME, Paisey R, Paisey R, Millward BA, Eccles C, Williams K, Hammersley S, MacLeod KM, Gale TJ: Short-term effects of severe dietary carbohydrate-restriction advice in Type 2 diabetes – a randomized controlled trial. Diabet Med 2006,23(1):15-20. 10.1111/j.1464-5491.2005.01760.x
Gannon MC, Nuttall FQ: Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition. Nutr Metab (Lond) 2006, 3: 16. 10.1186/1743-7075-3-16
Vernon M, Mavropoulos J, Transue M, Yancy W Jr, Westman E: Clinical Experience of a Carbohydrate-Restricted Diet: Effect on Diabetes Mellitus. Metabolic Syndrome and Related Disorders 2003, 1: 233-237. 10.1089/154041903322716714
Vernon MC, Eberstein JA: Atkins Diabetes Revolution. The Groundbreaking Approach to Preventing and Controlling Type 2 Diabetes. New York: William Morrow; 2004.
Yancy WS Jr, Vernon MC, Westman EC: A Pilot trial of a Low-Carbohydrate, Ketogenic Diet in Patients with Type 2 Diabetes. Metabolic Syndrome and Related Disorders 2003,1(3):239-243. 10.1089/154041903322716723
Reaven GM: Effect of dietary carbohydrate on the metabolism of patients with non-insulin dependent diabetes mellitus. Nutr Rev 1986,44(2):65-73.
Garg A, Bantle JP, Henry RR, Coulston AM, Griver KA, Raatz SK, Brinkley L, Chen YD, Grundy SM, Huet BA, et al.: Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA 1994,271(18):1421-1428. 10.1001/jama.271.18.1421
Westman EC, Yancy WS Jr, Haub MD, Volek JS: Insulin Resistance from a Low-Carbohydrate, High Fat Diet Perspective. Metabolic Syndrome and Related Disorders 2005, 3: 3-7. 10.1089/met.2005.3.14
Nielsen JV, Jonsson E, Nilsson AK: Lasting improvement of hyperglycaemia and bodyweight: low-carbohydrate diet in type 2 diabetes – a brief report. Ups J Med Sci 2005,110(1):69-73.
Eades MR, Eades MD: Protein Power. New York: Bantam Books; 1996.
Feinman RD, Fine EJ: Thermodynamics and Metabolic Advantage of Weight Loss Diets. Metabolic Syndrome and Related Disorders 2003,1(3):209-219. 10.1089/154041903322716688
Krieger JW, Sitren HS, Daniels MJ, Langkamp-Henken B: Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a meta-regression 1. Am J Clin Nutr 2006,83(2):260-274.
Volek JS, Feinman RD: Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) 2005, 2: 31. 10.1186/1743-7075-2-31
Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, Yancy WS, Phinney SD: Low-carbohydrate nutrition and metabolism. Am J Clin Nutr 2007,86(2):276-284.
Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S: A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003,348(21):2082-2090. 10.1056/NEJMoa022207
Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L: A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003,348(21):2074-2081. 10.1056/NEJMoa022637
Colpo A: The Great Cholesterol Con. Lulu Press; 2006.
German JB, Dillard CJ: Saturated fats: what dietary intake? Am J Clin Nutr 2004,80(3):550-559.
Karam J, Nessim F, McFarlane S, Feinman R: Carbohydrate Restriction and Cardiovascular Risk. Current Cardiovascular Risk Reports 2008,2(2):88-94. 10.1007/s12170-008-0018-z
Ravnskov U: The Cholesterol Myths: Exposing the Fallacy that Cholesterol and Saturated Fat Cause Heart Disease. Washington, DC: New Trends Publishing, Inc; 2000.
Taubes G: Good Calories, Bad Calories. New York: Alfred A. Knopf; 2007.
Volek JS, Forsythe CE: The case for not restricting saturated fat on a low carbohydrate diet. Nutr Metab (Lond) 2005, 2: 21. 10.1186/1743-7075-2-21
Keys A: Coronary heart disease in seven countries. 1970,41(Suppl):1-211.
Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, et al.: Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006,295(6):655-666. 10.1001/jama.295.6.655
Dreon DM, Fernstrom HA, Miller B, Krauss RM: Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEB J 1994,8(1):121-126.
Krauss RM: Atherogenic lipoprotein phenotype and diet-gene interactions. J Nutr 2001,131(2):340S-343S.
McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, Simon J, Krauss RM: Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005,96(3):399-404. 10.1016/j.amjcard.2005.03.085
Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, et al.: Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 2006,259(3):247-258. 10.1111/j.1365-2796.2006.01616.x
Ginsberg HN, Zhang YL, Hernandez-Ono A: Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005,36(3):232-240. 10.1016/j.arcmed.2005.01.005
Volek JS, Sharman MJ, Forsythe CE: Modification of lipoproteins by very low-carbohydrate diets. J Nutr 2005,135(6):1339-1342.
Vessby B: Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003,14(1):15-19. 10.1097/00041433-200302000-00004
Ravnskov U: The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol 1998,51(6):443-460. 10.1016/S0895-4356(98)00018-3
Dreon DM, Fernstrom HA, Campos H, Blanche P, Williams PT, Krauss RM: Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am J Clin Nutr 1998,67(5):828-836.
Mozaffarian D, Rimm EB, Herrington DM: Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr 2004,80(5):1175-1184.
Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC: Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997,337(21):1491-1499. 10.1056/NEJM199711203372102
Mensink RP, Zock PL, Kester AD, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003,77(5):1146-1155.
Raatz SK, Bibus D, Thomas W, Kris-Etherton P: Total fat intake modifies plasma fatty acid composition in humans. J Nutr 2001,131(2):231-234.
Cassady B, Charboneau N, Brys E, Crouse K, Beitz D, Wilson T: Effects of low carbohydrate diets high in red meats or poultry, fish and shellfish on plasma lipids and weight loss. Nutr Metab (Lond) 2007.,4(23):
Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, Kraemer WJ, Feinman RD, Volek JS: Comparison of low fat and low carbohydrate diets on circulating Fatty Acid composition and markers of inflammation. Lipids 2008,43(1):65-77. 10.1007/s11745-007-3132-7
Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Kahn BB, et al.: Inaugural Article: The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 2007,104(31):12587-12594. 10.1073/pnas.0705408104
Le KA, Tappy L: Metabolic effects of fructose. Curr Opin Nutr Metab Care 2006,9(4):469-475.
Rutledge AC, Adeli K: Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev 2007,65(6):S13-S23. 10.1301/nr.2007.jun.S13-S23
Zammit VA: Insulin stimulation of hepatic triacylglycerol secretion in the insulin-replete state: implications for the etiology of peripheral insulin resistance. Ann N Y Acad Sci 2002, 967: 52-65.
Lustig RH: Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics. Nature Clin Pract Endo Metab 2006,2(8):447-458. 10.1038/ncpendmet0220
Sharman MJ, Kraemer WJ, Love DM, Avery NG, Gomez AL, Scheett TP, Volek JS: A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr 2002,132(7):1879-1885.
Feinman RD, Volek JS: Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss. Nutr Metab (Lond) 2006, 3: 24. 10.1186/1743-7075-3-24
Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT: Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr 2006,83(5):1025-1031.
Agatston A: The South Beach Diet. New York: Random House; 2003.
Atkins RC: Dr. Atkins' New Diet Revolution. New York: Avon Books; 2002.
Larosa JC, Fry AG, Muesing R, Rosing DR: Effects of high-protein, low-carbohydrate dieting on plasma lipoproteins and body weight. J Am Diet Assoc 1980,77(3):264-270.
Yancy WS Jr, Foy M, Chalecki AM, Vernon MC, Westman EC: A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond) 2005, 2: 34. 10.1186/1743-7075-2-34
Volek JS, Sharman MJ, Gomez AL, Judelson DA, Rubin MR, Watson G, Sokmen B, Silvestre R, French DN, Kraemer WJ: Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women. Nutr Metab (Lond) 2004,1(1):13. 10.1186/1743-7075-1-13
Feinman RD, Vernon MC, Westman EC: Low carbohydrate diets in family practice: what can we learn from an internet-based support group. Nutr J 2006, 5: 26. 10.1186/1475-2891-5-26